Therefore, it can be concluded that 1,25-D3 promoted VEGF and TGF-β mRNA expression and reduced the expression of apoptotic factor P53 mRNA by activating VDR, thereby promoting angiogenesis after stroke, reducing apoptosis caused by mitochondrial metabolic disorders, and alleviating brain injury. The gene discussed is VEGFA; the disease is Stroke.